Cosa significa "Chiaro"?
L'animale non porta la mutazione. Non svilupperà la malattia e non lo trasmetterò.
Cane Gangliosidosi di tipo 2 variante 0 in Shiba Inu (GM2-var0-SI).
The DNA test for Gangliosidosis Type 2 Variant 0 (GM2-var0) in Shiba Inu dogs is essential for early detection of this rare genetic disorder. GM2-var0 affects the nervous system, leading to severe neurological symptoms and reduced quality of life. By identifying carriers and affected dogs through this DNA test, breeders can make informed decisions to prevent the spread of the disease. Early diagnosis allows for better management and care of affected Shiba Inus. This genetic screening supports responsible breeding practices and promotes healthier future generations. If you own a Shiba Inu, consider the GM2-var0 DNA test to safeguard your dog's health. Reliable testing helps protect this beloved breed from hereditary gangliosidosis.
Abbreviazione: GM2-var0-SI
Mutazione analizzata: HEXB c.849_851del CCT
Eredità: Autosomico recessivo
Acronimo
GM2-var0-SI
Frequenza osservata
Gravità clinica
Classificazione clinica
Malattie neurologiche
Mutazione analizzata
HEXB c.849_851del CCT
p.(L284del)
p.(L284del)
Modalità di ereditarietà
Autosomico recessivo (Completare)
Nome alternativo:
Sandhoff
Riepilogo del test:
The DNA test for Gangliosidosis Type 2 Variant 0 (GM2-var0) in Shiba Inu detects a genetic mutation responsible for a rare lysosomal storage disorder. This condition leads to the accumulation of harmful substances in nerve cells, causing neurological symptoms and progressive decline. Early identification through testing helps breeders avoid producing affected puppies. Carriers show no symptoms but can pass the mutation to offspring. Genetic screening is essential for maintaining the health and longevity of the Shiba Inu breed.
Disponibile dalla confezione: Basic
Questo test del DNA è incluso a partire dalla nostra confezione Basic — e fa anche parte dei pack Basic, Standard, Advanced, Complete.
Visualizza i pacchetti di test del DNA →Scegli il pack che meglio si adatta alla tua strategia di allevamento o di salute dei tuoi animali.
Understanding Gangliosidosis Type 2 Variant 0 (GM2-var0) in Shiba Inu
Gangliosidosis Type 2 Variant 0 (GM2-var0) is a genetic disorder affecting the Shiba Inu breed, characterized by a deficiency of the enzyme hexosaminidase A (Hex-A). This enzyme plays a crucial role in the breakdown of certain lipids in the body. When Hex-A is deficient, gangliosides, which are complex lipids found in nerve cells, accumulate abnormally, leading to neurological issues and other systemic problems.
Segni e sintomi clinici
Dogs affected by GM2-var0 may exhibit a range of clinical symptoms that typically manifest in early to middle life. Common signs include neurological dysfunction, which can present as loss of coordination, muscle weakness, and behavioral changes. Affected dogs may also show developmental delays or regression, difficulty in movement, and, in some cases, seizures. The severity and progression of symptoms may vary significantly among individual dogs.
Pathophysiology of GM2-var0
The pathophysiology of Gangliosidosis Type 2 Variant 0 involves the accumulation of GM2 gangliosides in the central nervous system and other tissues due to the impaired activity of the Hex-A enzyme. This accumulation leads to cellular damage and dysfunction, particularly in neurons. As a result, the myelin sheath, which insulates nerve fibers and facilitates efficient signal transmission, may also be affected, further exacerbating neurological deficits.
Diagnosis of GM2-var0
Diagnosis of GM2-var0 is achieved through genetic testing that identifies mutations in the HEXA gene responsible for the production of the Hex-A enzyme. Early diagnosis is critical, as it allows for better management of the condition and helps owners make informed decisions regarding the care of their pets. Genetic testing can also provide valuable information for breeders, helping to reduce the incidence of this condition in future generations.
Gestione e cura
While there is currently no cure for GM2-var0, supportive care can help improve the quality of life for affected dogs. This may include physical therapy, nutritional support, and medications to manage symptoms such as seizures or pain. Regular veterinary check-ups are essential to monitor the progression of the disease and adjust care as needed. Owners are encouraged to provide a stable and loving environment to enhance their pet's well-being.
Conclusione
Gangliosidosis Type 2 Variant 0 is a serious genetic condition in Shiba Inu that has significant implications for affected dogs and their owners. Awareness and understanding of GM2-var0 can lead to early detection and better management strategies, ultimately improving the lives of dogs diagnosed with this disorder. Responsible breeding practices, including genetic testing, can help mitigate the prevalence of GM2-var0 in the Shiba Inu population.
Razza riconosciuta per il test: Gangliosidosi di tipo 2 variante 0 in Shiba Inu (GM2-var0-SI).
- Shiba Inu
🧬 Interpretation of genotypes GM2-var0-SI
Genotipo
Stato
🟡 N/N
Non portatore: nessun rischio
🟡 N/GM2-var0-SI
Vettore: nessun rischio
❌ GM2-var0-SI/GM2-var0-SI
Interessato - A rischio
FAQ: comprendere l'interpretazione
Un “Portatore” è serio?
No. L'animale è generalmente sano ma può trasmettergli la mutazione prole.
Cosa succede se un animale è “affetto”?
Porta due copie mutate. I segni clinici sono attesi a seconda la malattia. Non dovrebbe essere allevato.
Perché ci sono differenze tra maschio/femmina?
Alcune malattie sono legate al sesso, quindi la loro espressione varia a seconda sesso dell'animale.
Predire la prole
N/N (non-portatore)
N/GM2-var0-SI (Vettore)
GM2-var0-SI/GM2-var0-SI (Ricercato)
Domande frequenti sul test del DNA
Cosa rileva questo test del DNA?
This DNA test detects the mutation associated with Gangliosidosis Type 2 Variant 0 In Shiba Inu (GM2-var0-SI) in order to identify clear, carrier, or at-risk animals.
Perché testare un animale riproduttore?
Il test del DNA aiuta gli allevatori a pianificare accoppiamenti più sicuri e a ridurre il rischio di trasmettere la mutazione alla prole.
Qual è la modalità di ereditarietà di questo test?
La modalità di ereditarietà riportata per questo test è Autosomica Recessiva.
Quale mutazione viene analizzata in questo test?
This test analyses the mutation HEXB c.849_851del CCT.
Un animale portatore è necessariamente affetto?
Non necessariamente. L'interpretazione dipende dal modello di ereditarietà e dal genotipo risultante.